Taking into account the various genes mutated in lung adenocarcinomas, the most frequent biochemical pathways showing key alterations were represented by: RTK/RAS/RAF pathway (76%), PI3K-mTOR pathway (25%), p53 pathway (63%), cell cycle (64%), chromatin and RNA splicing (22%) [13]. This evidence concerns the gene MTOR and lung adenocarcinoma.